Bloomberg Technology
23andMe CEO on Trading Debut, GSK Deal, Branson SPAC
Jun.17 — 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing company’s NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloomberg’s Emily Chang on “Bloomberg Markets: The Close.”
Aperture Online
June 17, 2021 at 8:52 pm
So does that mean that I can destroy my DNA with drugs so that I’m older to go public faster?
mrPmj00
June 17, 2021 at 11:44 pm
__…Stocks for the next 5 years: Amazon, Apple, Facebook, Microsoft, Netflix. Disney, Wells Fargo, Lowes for the
recovery.
My family and friends use things from these companies every day so I know that these companies will continue to do well.